Letter to the editor for the article “Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy”
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-05121-y ↗Kurz gefasst
Leserbrief in der Zeitschrift World Journal of Urology, 2024. Verfasst von Bei Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urinary Surgery, Institute of Urology, Peking University First Hospital, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Ciprofloxacin, Fosfomycin, Prostate, Anti-Bacterial Agents. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urinary Surgery, Institute of Urology, Peking University First Hospital, Peking University, Beijing, China.
- Department of Gastrointestinal Surgery, Peking University First Hospital, No.8 Xishku Street, Xicheng District, Beijing, China. pkudocyoung@outlook.com.
Zitieren
APA
Zhang, B., & Wang, Y. (2024). Letter to the editor for the article “Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy”. World Journal of Urology. https://doi.org/10.1007/s00345-024-05121-y
Vancouver
Zhang B, Wang Y. Letter to the editor for the article “Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy”. World Journal of Urology. 2024. doi:10.1007/s00345-024-05121-y
BibTeX
@article{Zhang2024,
author = {Zhang, Bei and Wang, Yajie},
title = {Letter to the editor for the article “Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy”},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-05121-y}
}
EUVIMED